| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
180,310,000 |
| Market
Cap: |
41.24(B) |
| Last
Volume: |
799,597 |
Avg
Vol: |
865,460 |
| 52
Week Range: |
$191.51 - $228.9 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
39,326 |
485,736 |
| Total Sell Value |
$0 |
$0 |
$8,245,949 |
$88,282,436 |
| Total People Sold |
0 |
0 |
7 |
8 |
| Total Sell Transactions |
0 |
0 |
18 |
71 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Akkaraju Srinivas |
Director |
– • – |
2018-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
32,205 |
|
- |
|
| Gryska David W |
Director |
– • – |
2018-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
45,050 |
|
- |
|
| Simonian Nancy A |
Director |
– • – |
2018-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
21,800 |
|
- |
|
| Baker Julian |
Director |
– • • |
2018-05-18 |
4 |
A |
$56.77 |
$420,098 |
I/I |
7,400 |
45,829,686 |
|
- |
|
| Cline Darren S |
EVP, Commercial |
• – – |
2018-05-09 |
4 |
S |
$55.33 |
$497,983 |
D/D |
(9,000) |
71,831 |
|
- |
|
| Cline Darren S |
EVP, Commercial |
• – – |
2018-05-09 |
4 |
OE |
$15.46 |
$145,790 |
D/D |
9,000 |
80,831 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2018-05-09 |
4 |
AS |
$54.17 |
$1,035,114 |
D/D |
(18,832) |
687,146 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2018-05-09 |
4 |
OE |
$11.09 |
$208,847 |
D/D |
18,832 |
693,886 |
|
- |
|
| Baker Julian |
Director |
– • • |
2018-05-08 |
4 |
B |
$54.02 |
$6,828,339 |
I/I |
126,399 |
45,825,986 |
2.25 |
- |
|
| Baker Julian |
Director |
– • • |
2018-05-07 |
4 |
B |
$53.70 |
$6,966,305 |
I/I |
129,715 |
45,699,587 |
2.25 |
- |
|
| Baker Julian |
Director |
– • • |
2018-05-04 |
4 |
B |
$52.68 |
$10,775,582 |
I/I |
204,537 |
45,569,872 |
2.25 |
- |
|
| Cline Darren S |
EVP, Commercial |
• – – |
2018-05-03 |
4 |
S |
$53.81 |
$215,238 |
D/D |
(4,000) |
71,831 |
|
- |
|
| Baker Julian |
Director |
– • • |
2018-05-02 |
4 |
B |
$51.88 |
$3,676,836 |
I/I |
69,947 |
45,365,335 |
2.25 |
- |
|
| Baker Julian |
Director |
– • • |
2018-05-01 |
4 |
B |
$51.14 |
$15,764,736 |
I/I |
306,917 |
45,295,388 |
2.25 |
- |
|
| Baker Julian |
Director |
– • • |
2018-05-01 |
4 |
OE |
$10.08 |
$201,600 |
I/I |
20,000 |
44,988,471 |
|
- |
|
| Baker Julian |
Director |
– • • |
2018-04-30 |
4 |
B |
$50.90 |
$31,816,925 |
I/I |
623,136 |
44,978,471 |
2.25 |
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2018-04-09 |
4 |
AS |
$50.52 |
$951,393 |
D/D |
(18,832) |
687,146 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2018-04-09 |
4 |
OE |
$11.09 |
$208,847 |
D/D |
18,832 |
705,978 |
|
- |
|
| Drachman Jonathan G |
CMO & EVP, R & D |
• – – |
2018-03-20 |
4 |
OE |
$10.61 |
$439,134 |
D/D |
31,039 |
201,973 |
|
- |
|
| Himes Vaughn B |
See Remarks |
• – – |
2018-03-15 |
4 |
AS |
$58.09 |
$290,604 |
D/D |
(5,000) |
164,906 |
|
- |
|
| Himes Vaughn B |
See Remarks |
• – – |
2018-03-15 |
4 |
OE |
$12.00 |
$60,000 |
D/D |
5,000 |
169,906 |
|
- |
|
| Seth Alpna |
Director |
– • – |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,750 |
5,750 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2018-03-09 |
4 |
AS |
$57.17 |
$1,079,436 |
D/D |
(18,832) |
687,146 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2018-03-09 |
4 |
OE |
$11.09 |
$208,847 |
D/D |
18,832 |
701,214 |
|
- |
|
| Drachman Jonathan G |
CMO & EVP, R & D |
• – – |
2018-03-05 |
4 |
AS |
$52.70 |
$552,452 |
D/D |
(10,457) |
170,934 |
|
- |
|
1805 Records found
|
|
Page 24 of 73 |
|
|
